Patients With Schizophrenia May Be Least Likely To Stop Treatment If Prescribed Clozapine Or LAI Formulations Of Aripiprazole, Paliperidone, Study Indicates

Psychiatric News (7/19) reports, “Patients with schizophrenia may be less likely to stop treatment if prescribed clozapine or the long-acting injectable (LAI) formulations of aripiprazole and paliperidone compared with oral olanzapine,” investigators concluded in a study that “made use of data from over 37,000 veterans.” The findings were published online July 14 in the American Journal of Psychiatry, a publication of the American Psychiatric Association.